Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001049404 | SCV001213452 | uncertain significance | not provided | 2024-01-23 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 2920 of the USH2A protein (p.Thr2920Ala). This variant is present in population databases (rs762358589, gnomAD 0.003%). This missense change has been observed in individuals with retinitis pigmentosa (PMID: 36819107; Invitae). ClinVar contains an entry for this variant (Variation ID: 846165). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on USH2A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Blueprint Genetics | RCV001073507 | SCV001239050 | likely pathogenic | Retinal dystrophy | 2019-04-09 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001832460 | SCV002090806 | uncertain significance | Usher syndrome type 2A | 2020-07-24 | no assertion criteria provided | clinical testing |